Umbilical cord stem cells injected into legs to fight diabetic nerve pain

NCT ID NCT07183761

Recruiting now Disease control Sponsor: Min Long Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injecting stem cells from umbilical cords into the legs can help people with moderate to severe diabetic nerve damage. 140 adults will get either stem cell shots plus standard care, or standard care alone, and be followed for 24 weeks. The goal is to see if the treatment improves nerve function and reduces pain safely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: human umbilical cord mesenchymal stem cells (hUC-MSCs)
What this could lead to: If it works, this could point toward a new treatment that reduces nerve pain and improves function in people with diabetic nerve damage.
What could go wrong: This is an early Phase 2 trial with only 140 people, so results may not apply to everyone. Stem cell therapies can have side effects like injection site reactions or immune responses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC PERIPHERAL NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic neuropathy diabetic polyneuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC PERIPHERAL NEUROPATHY (DPN)

Contacts and locations

Locations

Southwest Hospital
RECRUITING

Chongqing, Chongqing Municipality, 400038, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.